HCA Healthcare, Inc. $HCA Shares Sold by D.A. Davidson & CO.

D.A. Davidson & CO. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 35.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,363 shares of the company’s stock after selling 1,293 shares during the quarter. D.A. Davidson & CO.’s holdings in HCA Healthcare were worth $905,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Price T Rowe Associates Inc. MD raised its position in shares of HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock worth $829,104,000 after purchasing an additional 1,091,416 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares during the last quarter. Nuveen LLC acquired a new stake in shares of HCA Healthcare in the first quarter worth approximately $569,217,000. Pacer Advisors Inc. lifted its holdings in HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of HCA Healthcare by 6.8% in the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock valued at $350,404,000 after buying an additional 59,163 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HCA. Barclays upped their price objective on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a research note on Monday. Truist Financial lifted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research report on Monday. TD Cowen raised their target price on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday. JPMorgan Chase & Co. upped their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Finally, Stephens boosted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a report on Monday. Fourteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $473.53.

HCA Healthcare Trading Down 0.3%

HCA opened at $466.34 on Wednesday. The firm has a market cap of $109.12 billion, a price-to-earnings ratio of 18.03, a PEG ratio of 1.43 and a beta of 1.40. The stock’s 50-day moving average price is $417.60 and its 200 day moving average price is $384.15. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $469.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the business posted $4.90 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.